1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2025 - FRS102_2025 6,220,191 4,588,136 2,404,342 432,980 8,836,965 8,836,965 6,220,191 xbrli:pure xbrli:shares iso4217:GBP SC550593 2024-04-01 2025-03-31 SC550593 2025-03-31 SC550593 2024-03-31 SC550593 2023-04-01 2024-03-31 SC550593 2024-03-31 SC550593 2023-03-31 SC550593 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 SC550593 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 SC550593 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 SC550593 bus:OrdinaryShareClass4 2024-04-01 2025-03-31 SC550593 bus:OrdinaryShareClass5 2024-04-01 2025-03-31 SC550593 bus:Director1 2024-04-01 2025-03-31 SC550593 core:WithinOneYear 2025-03-31 SC550593 core:WithinOneYear 2024-03-31 SC550593 core:ShareCapital 2025-03-31 SC550593 core:ShareCapital 2024-03-31 SC550593 core:SharePremium 2025-03-31 SC550593 core:SharePremium 2024-03-31 SC550593 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC550593 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC550593 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 SC550593 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 SC550593 core:DisposalsRepaymentsInvestments core:Non-currentFinancialInstruments 2025-03-31 SC550593 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 SC550593 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 SC550593 core:Non-currentFinancialInstruments 2025-03-31 SC550593 core:Non-currentFinancialInstruments 2024-03-31 SC550593 bus:Director1 2024-03-31 SC550593 bus:Director1 2025-03-31 SC550593 bus:Director1 2023-03-31 SC550593 bus:Director1 2024-03-31 SC550593 bus:Director1 2023-04-01 2024-03-31 SC550593 bus:SmallEntities 2024-04-01 2025-03-31 SC550593 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 SC550593 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 SC550593 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC550593 bus:FullAccounts 2024-04-01 2025-03-31 SC550593 bus:OrdinaryShareClass1 2025-03-31 SC550593 bus:OrdinaryShareClass1 2024-03-31 SC550593 bus:OrdinaryShareClass2 2025-03-31 SC550593 bus:OrdinaryShareClass2 2024-03-31 SC550593 bus:OrdinaryShareClass3 2025-03-31 SC550593 bus:OrdinaryShareClass3 2024-03-31 SC550593 bus:OrdinaryShareClass4 2025-03-31 SC550593 bus:OrdinaryShareClass4 2024-03-31 SC550593 bus:OrdinaryShareClass5 2025-03-31 SC550593 bus:OrdinaryShareClass5 2024-03-31 SC550593 bus:AllOrdinaryShares 2025-03-31 SC550593 bus:AllOrdinaryShares 2024-03-31 SC550593 core:RevaluationPropertyDeferredTax 2025-03-31
COMPANY REGISTRATION NUMBER: SC550593
Every Field Has A Name Limited
Filleted Unaudited Financial Statements
31 March 2025
Every Field Has A Name Limited
Statement of Financial Position
31 March 2025
2025
2024
Note
£
£
£
Fixed assets
Investments
5
8,836,965
6,220,191
Current assets
Debtors
6
695
13,576
Cash at bank and in hand
234,884
1,087,013
----------
-------------
235,579
1,100,589
Creditors: amounts falling due within one year
7
88,237
14,861
----------
-------------
Net current assets
147,342
1,085,728
-------------
-------------
Total assets less current liabilities
8,984,307
7,305,919
Provisions
115,738
-------------
-------------
Net assets
8,868,569
7,305,919
-------------
-------------
Capital and reserves
Called up share capital
9
163
135
Share premium account
3,256,330
1,896,865
Profit and loss account
5,612,076
5,408,919
-------------
-------------
Shareholders funds
8,868,569
7,305,919
-------------
-------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 31st March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Every Field Has A Name Limited
Statement of Financial Position (continued)
31 March 2025
These financial statements were approved by the board of directors and authorised for issue on 20 November 2025 , and are signed on behalf of the board by:
Mr T P Walton
Director
Company registration number: SC550593
Every Field Has A Name Limited
Notes to the Financial Statements
Year ended 31st March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 73 Oxgangs Road, Edinburgh, EH10 7BA, Scotland.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Investments
Fixed asset investments are initially recorded a cost, and subsequently stated at cost less any accumulated impairment losses
Investment properties are revalued to their fair values at each reporting date and any change in fair value are recognised in profit and loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
5. Investments
Other investments other than loans
£
Cost
At 1st April 2024
6,220,191
Additions
4,588,136
Disposals
( 2,404,342)
Revaluations
432,980
-------------
At 31st March 2025
8,836,965
-------------
Impairment
At 1st April 2024 and 31st March 2025
-------------
Carrying amount
At 31st March 2025
8,836,965
-------------
At 31st March 2024
6,220,191
-------------
Included in the above is a number of investment properties. On 31st March 2025 the investment properties were valued by Mr T P Walton , a director of the company, on an open market value basis in the sum of £2,853,813 (31st March 2024 - £2,147,015).
6. Debtors
2025
2024
£
£
Other debtors
695
13,576
----
---------
7. Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
88,237
14,861
---------
---------
8. Deferred tax
The deferred tax included in the statement of financial position is as follows:
2025
2024
£
£
Included in provisions
115,738
----------
----
The deferred tax account consists of the tax effect of timing differences in respect of:
2025
2024
£
£
Other revaluations
115,738
----------
----
9. Called up share capital
Issued, called up and fully paid
2025
2024
No.
£
No.
£
Ordinary shares of £ 0.01 each
8,000
80
10,000
100
Ordinary A shares of £ 0.01 each
1,629
16
868
9
Ordinary B shares of £ 0.01 each
1,629
16
868
9
Ordinary C shares of £ 0.01 each
1,629
16
868
9
Ordinary D shares of £ 0.01 each
1,629
16
868
9
Ordinary E shares of £0.01 each
427
4
Ordinary F shares of £0.01 each
862
9
Ordinary G shares of £0.01 each
465
5
---------
----
---------
----
16,270
163
13,472
135
---------
----
---------
----
10. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2025
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Mr T P Walton
( 2,043)
( 23,644)
( 25,687)
-------
---------
---------
2024
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Mr T P Walton
( 58,599)
56,556
( 2,043)
---------
---------
-------
The non-interest bearing loan is repayable on demand.